Skip to content
10-K

Annual Report

Entia Biosciences, Inc.

0001185185-16-004208

← back to feed
Filed
Apr 14, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Apr 13, 2016 28.13M sh
Capex FY 2015 · Dec 31, 2014 $4.61K
Operating Cash Flow FY 2015 · Dec 31, 2014 −$680.28K
Current Liabilities FY 2015 · Dec 31, 2014 $987.24K
Total Liabilities FY 2015 · Dec 31, 2014 $987.24K
Current Assets restated FY 2015 · Dec 31, 2014 $437.39K
Total Assets FY 2015 · Dec 31, 2014 $870.71K
Sga Expense FY 2015 · Dec 31, 2014 $1.5M
Rd Expense FY 2015 · Dec 31, 2014 $24.52K
Net Income FY 2015 · Dec 31, 2014 −$2.3M
Operating Income FY 2015 · Dec 31, 2014 −$1.8M
Gross Profit FY 2015 · Dec 31, 2014 $410.87K
Cost Of Revenue FY 2015 · Dec 31, 2014 $245.47K
Revenue FY 2015 · Dec 31, 2014 $656.34K
Cash And Equivalents FY 2015 · Dec 31, 2013 $36.89K